Global Antifungal Agents Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Antifungal Agents Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global antifungal agents market report has been segmented on the basis of drug type, infection type, dosage forms, and region.
Global Antifungal Agents Market: Overview
Anti-fungal agent is a drug detects and removes fungal pathogens from body with negligible toxic side effects to a body. Antifungal agents are also called as antimycotic medication which is used for prevent fungal infection. Fungal infection in body is occurred due to unclean and unhygienic environments wherein fungal agent thrive. Antifungal agents multiply by spreading spores which subsequently lead to infection on skin or when inhaled-fungal infections. Fungal infection leads to mucormycosis, fungal pneumonia, candidiasis, and various other diseases.
Global Antifungal Agents Market: Dynamics
Increasing awareness unhygienic environment and skin infection is a major factor expected to propel growth of the global antifungal agent’s market. In addition, rising demand for antifungal agent’s in order to treat various infections such as fungal pneumonia, non-lethal infection, and mucormycosis is another key factor expected to boost the target market growth.
Increasing healthcare expenditure and increasing individual medical spending capacity in developed regions are other key factors anticipated to fuel growth of the global antifungal agent’s market. Moreover, increasing technological advancements in pharmaceuticals research for development antifungal drugs is another factor expected to proliferate growth of the global market.
However, presence of various counterfeit drugs and population with antifungal drug resistance are major factors expected to hamper growth of global antifungal agent’s market.
Global Antifungal Agents Market: Segment Analysis
Global antifungal agents market is segmented on the basis of drug type, infection type, dosage forms, and region.
Among the drug type segments, the azoles segment is projected to account for highest share in terms of revenue in the global antifungal agent products market. This is due to the azoles antifungal agents treats fungal infection in different areas of body such as fungal nail infections, athlete's foot, ringworm, and vaginal candidiasis.
Among the infection type segments, the global market is segmented into superficial antifungal infections and systemic antifungal infections. The superficial antifungal infections segment is expected to account for significant share in terms of revenue in the global market.
Global Antifungal Agents Market: Region Analysis
The North America market accounted for highest revenue share and is expected to dominate the global market over the forecast period. This is attributed to occurrence of infectious diseases and presence of established pharmaceutical companies in countries such as Canada and the US in the region.
The Asia Pacific market is expected to register fastest growth in the global market followed by Europe, owing to growing awareness regarding various antifungal agents and its treatments in countries such as China, India, France, and the UK, among others.
The market in Latin America and Middle East & Africa are expected to witness inclining growth, owing to growing awareness regarding health issues and easy availability of these drugs in countries in this region.
Global Antifungal Agents Market Segmentation:
Segmentation by Drug Type:
Segmentation by Infection Type:
- Superficial Antifungal Infections
- Systemic Antifungal Infections
Segmentation by Dosage Forms:
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Abbott Laboratories, Inc.
- Bayer Healthcare AG
- Gilead Sciences, Inc.
- Pfizer, Inc.
- Astellas Pharma, Inc.
- Basilea Pharmaceutical Ltd
- Sigma-Aldrich Corporation
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- Kramer Laboratories
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!